Clinical Trials
4
Active:0
Completed:0
Trial Phases
2 Phases
Phase 4:3
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 4
3 (75.0%)Not Applicable
1 (25.0%)th2 Modulation CRSwNP
Phase 4
Not yet recruiting
- Conditions
- Chronic Rhinosinusitis With Nasal Polyps
- Interventions
- First Posted Date
- 2023-10-30
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- St. Paul's Sinus Centre
- Target Recruit Count
- 40
- Registration Number
- NCT06107101
- Locations
- 🇨🇦
St. Paul's Sinus Centre, Vancouver, British Columbia, Canada
Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab Treatment
Phase 4
Recruiting
- Conditions
- Chronic Rhinosinusitis With Nasal PolypsAsthmaChronic Rhinosinusitis Without Nasal Polyps
- First Posted Date
- 2022-12-08
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- St. Paul's Sinus Centre
- Target Recruit Count
- 90
- Registration Number
- NCT05642806
- Locations
- 🇨🇦
St. Pual's Sinus Centre, Vancouver, British Columbia, Canada
Allergic Rhinitis Combination Pharmacotherapy Efficacy Study
Phase 4
Withdrawn
- Conditions
- Allergic Rhinitis
- Interventions
- First Posted Date
- 2020-10-23
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- St. Paul's Sinus Centre
- Registration Number
- NCT04601324
Utility of Indocyanine Green Fluorescence in Endoscopic Sinonasal and Skull Base Surgery
Not Applicable
Not yet recruiting
- Conditions
- Chronic SinusitisPosterior EpistaxisSkull Base NeoplasmsTumor of Nasal Sinus
- First Posted Date
- 2020-05-05
- Last Posted Date
- 2022-11-14
- Lead Sponsor
- St. Paul's Sinus Centre
- Target Recruit Count
- 40
- Registration Number
- NCT04374448
News
No news found